|Articles|October 1, 2020
Study & Test Kit during a Pandemic
Author(s)Cerba Research
Cerba Research initiated custom kit building & distribution for an infectious disease study, during the COVID-19 pandemic, in 10 days. A typical timeline is 8 weeks.
Newsletter
Stay current in clinical research with Applied Clinical Trials, providing expert insights, regulatory updates, and practical strategies for successful clinical trial design and execution.
Related Articles
2025 FSP Trends ReportJune 26th 2025
Trending on Applied Clinical Trials Online
1
IQVIA and Veeva Join Forces to Improve Efficiency and Patient Outcomes
2
Enhancing Clinical Trial Data Accuracy Through the IQVIA and Veeva Partnership
3
Everything to Know About FDA’s Push Towards Radical Transparency in 2025
4
How the NIMBLE Study Supported Adherence With Quarterly Dosing of Cemdisiran
5
.png "BioPharm International")
.png "Pharmaceutical Commerce"){kind=logo}
.png "Turbo Machinery Magazine")
.png){kind=spacer}
